Recent Advances in the Treatment of Metastatic Soft Tissue Sarcoma

Recent Advances in the Treatment of Metastatic Soft Tissue Sarcoma

Soft tissue sarcomas (STS) are a rare group of heterogeneous malignancies with >50 histologic subtypes that have varying biological behaviour and responsiveness to systemic therapy. The mainstay of therapy for metastatic STS in recent decades has been doxorubicin. To improve survival outcomes, nu...

Full description

Bibliographic Details
Main Authors: Elizabeth J. Davis, Vicki L. Keedy
Format: Article
Language:English
Published: European Medical Journal 2018-12-01
Series:European Medical Journal Oncology
Subjects:
eribulin
ipilimumab
nivolumab
olaratumab
pembrolizumab
soft tissue sarcoma (sts)
trabectedin
Online Access:https://www.emjreviews.com/oncology/article/recent-advances-in-the-treatment-of-metastatic-soft-tissue-sarcoma/

Internet

https://www.emjreviews.com/oncology/article/recent-advances-in-the-treatment-of-metastatic-soft-tissue-sarcoma/

Similar Items